Dana Zakalik

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Breast Cancer Risk

Health Promotion

Sentinel Lymph Node

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Neelam V Desai, Dana Zakalik, Mark R Somerfield, Nadine M Tung
Q and A: A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer. JCO oncology practice 18 (6) (2022)
Nadine M Tung, Dana Zakalik, Mark R Somerfield, null null
Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)